NPI: 1952405425 · PONCE, PR 00717 · 207RH0003X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,640 | $256K |
| 2019 | 8,022 | $384K |
| 2020 | 14,451 | $654K |
| 2021 | 14,093 | $647K |
| 2022 | 13,894 | $794K |
| 2023 | 9,897 | $681K |
| 2024 | 7,202 | $537K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q0084 | Chemotherapy by infusion | 16,690 | 6,742 | $1.32M |
| 96413 | 9,742 | 4,779 | $792K | |
| 96415 | 5,318 | 2,745 | $428K | |
| 99214 | 5,867 | 4,793 | $401K | |
| 96367 | 7,247 | 3,111 | $222K | |
| 96366 | 6,860 | 2,769 | $217K | |
| 96365 | 2,789 | 865 | $122K | |
| 99213 | 2,573 | 2,290 | $100K | |
| 99070 | 8,156 | 3,568 | $78K | |
| 96409 | 1,198 | 645 | $72K | |
| 99204 | 539 | 417 | $52K | |
| 96402 | 1,377 | 845 | $32K | |
| 96416 | 103 | 50 | $31K | |
| 96523 | 2,051 | 1,143 | $26K | |
| 96417 | 441 | 291 | $22K | |
| 99223 | Prolong inpt eval add15 m | 229 | 206 | $16K |
| 96372 | 1,042 | 347 | $13K | |
| 99203 | 182 | 171 | $6K | |
| G2012 | Brief check in by md/qhp | 169 | 152 | $3K |
| 99233 | Prolong inpt eval add15 m | 32 | 14 | $756.40 |
| J7030 | Normal saline solution infus | 253 | 134 | $186.35 |
| J1100 | Dexamethasone sodium phos | 138 | 67 | $90.44 |
| J1200 | Diphenhydramine hcl injectio | 128 | 63 | $32.85 |
| S0028 | Injection, famotidine, 20 mg | 75 | 38 | $1.93 |